Jinxin Fertility Group Limited
Jinxin Fertility Group Limited
Your view on JXFGF
Overview
What the company does, where it operates, and who runs it.
About Jinxin Fertility Group Limited
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Yang Dong
- Headquarters
- No. 301, North Jingsha Road, Chengdu, CN
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Yang Dong
- Headquarters
- No. 301, North Jingsha Road, Chengdu, CN
Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States.
The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband's sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection.
It also provides related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS. In addition, the company offers management services; medical services in the areas of gynecology, urology, and internal medicine; ambulatory surgery center facilities services; and ancillary medical services.
Further, it offers pre-implantation genetic screening testing services; and engages in the investment management and management consultancy, and real estate development and operation activities. Jinxin Fertility Group Limited was founded in 2003 and is headquartered in Chengdu, China.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Jinxin Fertility Group Limited, and the rating behind it. JXFGF last traded at $0.29, 24.9× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Jinxin Fertility Group Limited. Starting points for Jinxin Fertility Group Limited: P/E 24.9, EPS $0.06, beta 0.93 — an Medical - Care Facilities name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Jinxin Fertility Group Limited. Jinxin Fertility Group Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Jinxin Fertility Group Limited. Trailing twelve-month EPS for Jinxin Fertility Group Limited stands at $0.06. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Jinxin Fertility Group Limited. Jinxin Fertility Group Limited has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Jinxin Fertility Group Limited valued side by side against its closest peers. Jinxin Fertility Group Limited is measured against Medical - Care Facilities peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Jinxin Fertility Group Limited, and how their positions are changing. At a $782.5M market value, institutional positions materially move Jinxin Fertility Group Limited's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Jinxin Fertility Group Limited executives and directors. Shares of Jinxin Fertility Group Limited have traded between $0.20 and $0.50 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Jinxin Fertility Group Limited. Jinxin Fertility Group Limited is a $782.5M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Jinxin Fertility Group Limited. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Jinxin Fertility Group Limited. Coverage tracks Jinxin Fertility Group Limited within Medical - Care Facilities (Healthcare). Press releases and market coverage, newest first.